| Literature DB >> 27934649 |
Catherine J McNeal1, Cynthia J Meininger2, Deepika Reddy3, Colin D Wilborn4, Guoyao Wu5.
Abstract
l-Arginine (Arg) appears to have a beneficial effect on the regulation of nutrient metabolism to enhance lean tissue deposition and on insulin resistance in humans. The observed safe level for oral administration of Arg is ∼20 g/d, but higher levels have been tested in short-term studies without serious adverse effects; however, more data are needed in both animal models and humans to fully evaluate safety as well as efficacy. The primary objective of this review is to summarize the current knowledge of the safety, pharmacokinetics, and effectiveness of oral Arg in adults. Arg supplementation has been used safely in vulnerable populations, such as pregnant women, preterm infants, and individuals with cystic fibrosis. Several recent studies have shown beneficial effects of Arg in individuals with obesity, insulin resistance, and diabetes. Collectively, the data suggest that Arg supplementation is a safe and generally well-tolerated nutriceutical that may improve metabolic profiles in humans.Entities:
Keywords: adiposity; arginine; arginine pharmacokinetics; arginine safety; efficacy of arginine; insulin resistance
Mesh:
Substances:
Year: 2016 PMID: 27934649 DOI: 10.3945/jn.116.234740
Source DB: PubMed Journal: J Nutr ISSN: 0022-3166 Impact factor: 4.798